Patent ID: 8273859
Filing Date: 2012-09-25
Classification: A61K,A61P,C07K,G01N

Abstract:
1. A diagnostic drug for pancreatic cancer comprising an anti-AMIGO2 monoclonal antibody, wherein the anti-AMIGO2 monoclonal antibody is produced by at least one hybridoma cell line selected from the group consisting of a hybridoma cell line identified as PPMX0502 and deposited as FERM BP-10809, a hybridoma cell line identified as PPMX0504 and deposited as FERM BP-10810, a hybridoma cell line identified as PPMX0507 and deposited as FERM BP-10811, a hybridoma cell line identified as PPMX0508 and deposited as FERM BP-10812, and a hybridoma cell line identified as PPMX0519 and deposited as FERM BP-10813.